Abstract
Objective
To determine if oropharyngeal therapy with mother’s own milk (OPT-MOM) reduces late-onset sepsis (L-OS; primary outcome), NEC, death, length of stay, time to full enteral nutrition (FEN) and full oral feeds in preterm infants (BW < 1250 g).
Design
Infants (N = 220) were randomized to Group A (milk) or B (placebo) and received 0.2 mL every 2 h for 48 h, then every 3 h until 32 weeks CGA.
Results
There were no significant differences in L-OS, NEC or death. Group A trended towards an 8-day reduction in stay, 8-day reduction in time to FEN and a 6-day reduction in time to full oral feeds, compared to B. While clinically relevant, due to large variability in outcomes and lack of power, p values were > 0.05.
Conclusion
OPT-MOM did not reduce L-OS, NEC or death. Group A trended towards a reduced stay and better nutritional outcomes, but results were not statistically significant.
ClinicalTrials.gov
NCT02116699.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Change history
16 January 2023
A Correction to this paper has been published: https://doi.org/10.1038/s41372-023-01607-6
References
Garofalo NA, Caplan MS. Oropharyngeal mother’s milk: state of the science and influence on necrotizing enterocolitis. Clin Perinatol. 2019;46:77–88.
Rodriguez NA, Meier PP, Groer MW, Zeller JM, Engstrom JL, Fogg L. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother’s colostrum to extremely low birth weight infants. Adv Neonatal Care. 2010;10:206–12.
Montgomery DP, Baer VL, Lambert DK, Christensen RD. Oropharyngeal administration of colostrum to very low birth weight infants: results of a feasibility trial. Neonatal Intensive Care. 2010;23:27–29.
Rodriguez NA, Groer MW, Zeller JM, Engstrom JL, Fogg L, Du H, et al. A randomized clinical trial of the oropharyngeal administration of mother’s colostrum to extremely low birth weight infants in the first days of life. Neonatal Intensive Care. 2011;24:31–35.
Thibeau S, Boudreaux C. Exploring the use of mother’s own milk as oral care for mechanically ventilated very low birth weight infants. Adv Neonatal Care. 2013;13:190–7.
Seigel JK, Smith PB, Ashley PL, Cotten CM, Herbert CC, King BA, et al. Early administration of oropharyngeal colostrum to extremely low birthweight infants. Breastfeed Med. 2013;8:491–5.
Lee J, Kim HS, Jung YH, Choi KY, Shin SH, Kim EK, et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics. 2015;135:e357–366.
Rodriguez N, Vento M, Claud EC, Wang E, Caplan MS. Oropharyngeal administration of mother’s colostrum: Health outcomes of premature infants: study protocol for a randomized controlled trial. Trials. 2015;16:453.
Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infection. Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low birth weight neonates: a randomized trial. JAMA. 2009;302:1421–8.
Mai V, Torrazza RM, Ukhanova M, Wang X, Sun Y, Li N, et al. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS ONE. 2013;8:e52876.
Glass KM, Greecher CP, Doheny KK. Oropharyngeal administration of colostrum increases salivary secretory IgA levels in very low birth weight infants. Am J Perinatol. 2017;34:1389–95.
Zhang Y, Ji F, Hu X, Cao Y, Latour JM. Oropharyngeal colostrum administration in very low birth weight infants: A randomized controlled trial. Pediatr Crit Care Med. 2017;18:869–75.
Ferreira DMLM, Oliveira AMM, de Leves DV, de Bem EB, Fatureto GG, Navarro NF, et al. Randomized controlled trial of oropharyngeal colostrum administration in very-low-birth-weight preterm infants. J Pediatr Gastroenterol Nutr. 2019;69:126–30.
Aggarwal R, Plakkal N, Bhat V. Does oropharyngeal administration of colostrum reduce morbidity and mortality in very preterm infants? A randomised parallel-group controlled trial. J Paediatr Child Health. 2021;57:1467–72.
Abd-Elgawad M, Eldegla H, Khashaba M, Nasef N. Oropharyngeal administration of mother’s milk prior to gavage feeding in preterm infants: a pilot randomized control trial. J Parenter Enter Nutr. 2020;44:92–104.
Romano-Keeler J, Azcarate-Peril MA, Weitkamp JH, Slaughter JC, McDonald WH, Meng S, et al. Oral colostrum priming shortens hospitalization without changing the immune-microbial milieu. J Perinatol. 2017;37:36–41.
Sharma D, Kaur A, Farahbakhsh N, Agarwal S. Role of oropharyngeal administration of colostrum in very low birth weight infants for reducing necrotizing enterocolitis: a randomized controlled trial. Am J Perinatol. 2020;37:716–21.
Chen XC, Tong YF, Han ZM, Lin ZL. The effects of early oropharyngeal administration of microdosed colostrum on feeding status in ventilated extremely low-birth-weight infants. Breastfeed Med. 2021;16:648–53.
OuYang X, Yang CY, Xiu WL, Hu YH, Mei SS, Lin Q. Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤32 weeks: a pilot single-center randomized controlled trial. Int Breastfeed J. 2021;16:59.
Martín-Álvarez E, Diaz-Castro J, Pena-Cabellero M, Serrano-Lopez L, Moreno-Fernandez J, Sanchez-Martinez B, et al. Oropharyngeal colostrum positively modulates the inflammatory response in preterm neonates. Nutrients. 2020;12:E413.
Chen LL, Mu XH, Zhang XY, Yang CZ, Xiong XY, Wang MQ. Oropharyngeal administration of mother’s own milk influences levels of salivary sIgA in preterm infants fed by gastric tube. Sci Rep. 2022;9:2233.
Jain S, Kumar M, Tripathi S, Singh SN. Oral application of mother’s own milk for prevention of late onset sepsis in preterm very low birth weight neonates: a randomized controlled trial. Breastfeed Med. 2022;17:59–64.
Wahyuni F, Rustina Y, Efendi D. Oral care prevents late-onset sepsis in risk preterm infants. J Keperawatan Indones. 2020;23:31–40.
Moreno-Fernandez J, Sanchez-Martinez B, Serrano-Lopez L, Martin-Alvarez E, Diaz-Castro J, Pena-Cabellero M, et al. Enhancement of immune response mediated by oropharyngeal colostrum administration in preterm neonates. Pediatr Allergy Immunol. 2019;30:234–41.
Maffei D, Brewer M, Codipilly C, Weinberger B, Schanler RJ. Early oral colostrum administration in preterm infants. J Perinatol. 2020;40:284–7.
Ferreira DMLM, Oliveira AMM, de Leves DV, de Bem EB, Fatureto GG, Navarro NF, et al. Oropharyngeal colostrum administration and anti-inflammatory effects in very low birth weight preterm neonates. Acta Sci Paediatrics. 2021;4:39–47.
Tao J, Mao J, Yang J, Su Y. Effects of oropharyngeal administration of colostrum on the incidence of necrotizing enterocolitis, late-onset sepsis, and death in preterm infants: a meta-analysis of RCTs. Eur J Clin Nutr. 2020;74:1122–31.
Ma A, Yang J, Li Y, Zhang X. Oropharyngeal colostrum therapy reduces the incidence of ventilator-associated pneumonia in very low birth weight infants: a systematic review and meta-analysis. Pediatr Res. 2021;89:54–62.
Sherman MP, Adamkin DH, Niklas V, Radmacher P, Sherman J, Wertheimer F, et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. J Pediatr. 2016;175:68–73.
Funding
Supported by a grant from the Gerber Foundation (primary study sponsor-grant number 3877), the Associate Board of NorthShore University HealthSystem and an Anonymous Donor.
Author information
Authors and Affiliations
Contributions
Conception and design of the study: NAR, MSC, MV, EC, CW. Acquisition of data: FM, JL, AZ, PP, JP. Analysis and interpretation of data: CW, MSC. Drafting of manuscript: NAR. Critical revision and final approval of the version to be published: all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Consent statement
Patient consent was required for this study. The subjects (infants) were enrolled in the study only after voluntary informed consent was obtained from the parents.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The author’s name John Ladino has been corrected.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rodriguez, N.A., Moya, F., Ladino, J. et al. A randomized controlled trial of oropharyngeal therapy with mother’s own milk for premature infants. J Perinatol 43, 601–607 (2023). https://doi.org/10.1038/s41372-022-01589-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-022-01589-x